FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Fibromyalgia related Press Releases

Pierre Fabre Médicament is Granted Authorisation in Australia to Market the Milnacipran JONCIA® to Treat Fibromyalgia

Posted November 21, 2011

CASTRES, France, November 21, 2011 /PRNewswire/ -- The Therapeutic Goods Administration (TGA), Australia's regulatory body for therapeutic products, granted Pierre Fabre Médicament's milnacipran Read more...

The Fibromyalgia Drug Market Will Experience Minimal Growth over the Next Decade, Increasing from Nearly $1.6 Billion in 2

Posted September 29, 2011

In 2010, Eli Lilly/Boehringer Ingelheim’s Cymbalta Supplanted Pfizer’s Lyrica as the Market- and Patient-Share Leader in the U.S. Fibromyalgia Market, According to Findings from Decision Resources Read more...

TONIX Pharmaceuticals Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms an

Posted June 16, 2011

Presented at the Associated Professional Sleep Societies, June 2011 25th Anniversary Meeting in Minneapolis, MN NEW YORK--(BUSINESS WIRE)-- TONIX Pharmaceuticals, a specialty pharmaceutical company Read more...

U.S. Fibromyalgia Patients Currently Taking an Approved Therapy are More Likely to Request a Discontinuation of Their Trea

Posted March 30, 2011

EXTON, Penn.--(BUSINESS WIRE)-- Data from a recent report from BioTrends Research Group suggest that U.S. fibromyalgia patients who are currently taking one of the three agents approved for the Read more...

TONIX Pharmaceuticals to Present at the OneMedForum San Francisco 2011 on January 11 and at the Biotech Showcase™ on Janua

Posted January 4, 2011

NEW YORK--(BUSINESS WIRE)-- TONIX Pharmaceuticals (formerly known as Krele Pharmaceuticals), a specialty pharmaceutical company focused on central nervous system (CNS) disorders, announced today the Read more...

Meda Acquires Exclusive Rights to flupirtine for fibromyalgia, a Potential USD Billion Indication

Posted May 7, 2010

STOCKHOLM--(BUSINESS WIRE)-- Meda (STO:MEDAA) has acquired exclusive US, Canadian and Japanese rights for the use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals. As part of the Read more...

European CHMP Adopts Negative Opinion on Eli Lilly, Boehringer Ingelheim's Cymbalta for the Treatment of Fibromyalgia

Posted October 24, 2008

European CHMP Adopts Negative Opinion on Eli Lilly, Boehringer Ingelheim's Cymbalta for the Treatment of Fibromyalgia INDIANAPOLIS, Oct. 24 /PRNewswire-FirstCall/ -- The Committee for Medicinal

Read more...

Forest Laboratories, Cypress Bioscience Fibromyalgia Drug Delayed at FDA

Posted October 20, 2008

Forest Laboratories, Cypress Bioscience Fibromyalgia Drug Delayed at FDA NEW YORK and SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX - News) and Cypress Bioscience, Read more...

JAZZ PHARMACEUTICALS, INC. ANNOUNCES FINAL PATIENT HAS COMPLETED PHASE III CLINICAL TRIAL OF SODIUM OXYBATE TO TREAT FIBROMYALGI

Posted September 11, 2008

JAZZ PHARMACEUTICALS, INC. ANNOUNCES FINAL PATIENT HAS COMPLETED PHASE III CLINICAL TRIAL OF SODIUM OXYBATE TO TREAT FIBROMYALGIA PALO ALTO, Calif., Sept. 11 -- Jazz Pharmaceuticals, Inc. (Nasdaq: Read more...

PRESS RELEASE: Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome

Posted November 8, 2007

Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show NEW YORK, Nov. 8  -- Total daily dosages of milnacipran 100 mg and 200 mg Read more...
12next ›last »